Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

MK-8507 Extended Multiple Dose Study Ended

2023-506697-12-00 HIV-1 infection 3 2023-10-20
MK-3508 Multiple Ascending Dose Study in Healthy Participants Ended

2023-505821-15-00 Respiratory syncytial virus infection 3 2023-10-12
Implementation of Out-of-HOspital administration of the Long-Acting combination cabotegravir+rilpivirine as an optional therapy in HIV-Infec… Ended

2023-503963-41-00 HIV-Infected patients 6 2023-10-05
An open label, randomized, three-period, three-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of… Ended

2023-504760-42-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-09-27
CMV preemptive therapy in high-risk immunocompetent major heart surgery patients. A multicenter, double blind, randomized, clinical trial (G… Ended

2022-501429-19-00 Cytomegalovirus in high-risk immunocompetent major hear 5 2023-09-19
A trial to evaluate safety and characteristics of a substance for treatment of chronic hepatitis Ended

2023-503880-40-00 Chronic hepatitis B 4 2023-09-19
A phase II, randomized, double-blind, multi-centre trial to evaluate the safety and immunogenicity of BIMERVAX® when coadministered with sea… Ended

2023-506189-29-00 SARS-CoV-2 and Influenza 4 2023-09-04
Intradermal administration of a COVID-19 mRNA vaccine in elderly Ended

2023-503800-99-00 Adult volunteers (M/F) aged ≥75 years who are healthy o 4 2023-09-04
A Study to Learn How Different Manufactured Products of the Study Medicine Called Sisunatovir are Taken Up Into the Blood When Taken on an E… Ended

2023-505228-79-00 RSV (Respiratory Syncytial Virus) 3 2023-08-28
PREPARE-iVAC Ended

2023-503894-39-00 kidney transplantation 11 2023-08-22
A Phase III, open-label, randomized, controlled, multi-country study to evaluate the immune response, safety, and reactogenicity of respirat… Ended

2022-501988-40-00 RSV-associated (subtypes A and B) disease in adults age 5 2023-08-17
A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized… Ended

2022-501020-19-01 COVID-19 5 2023-07-31
A study on the immune response and safety of a combined measles, mumps, rubella, chickenpox vaccine compared to a marketed combined vaccine,… Ended

2022-501564-18-00 Healthy volunteers (prevention of measles, mumps, rubel 4 2023-07-31
A Study to Learn About the Taste Profiles of Different Suspensions of Study Medicine Called PF-07923568 in Healthy Adult Participants Ended

2023-504924-24-00 RSV (respiratory syncytial virus) 3 2023-07-25
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who are Healthy Volunteers Co-administered the Medicine Ro… Ended

2023-503570-20-00 coronavirus disease 2019 (COVID-19) 3 2023-06-02
A study to investigate improvement in physical function in SF-36 with Vericiguat compared with Placebo in participants with post-COVID-19 sy… Ended

2024-517713-33-00 Post-COVID-19 syndrome without (PCS) or with (PCS/CFS) 4 2023-05-31
Open-label, Multi-centre, Non-Inferiority study of safety and immunogenicity of BIMERVAX as heterologous booster for the prevention of coron… Ended

2023-504639-42-00 SARS-CoV-2 infection 4 2023-05-26
Treatments of COVID-19 in primary care in the Netherlands Ended

2022-501559-99-00 Patients with symptomatic COVID-19 in the community and 6 2023-05-25
STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BEMNIFOSBUVIR AND RUZASVIR IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION Ended

2023-504566-28-00 Chronic Hepatitis C Virus (HCV) Infection 4 2023-05-19
Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment… Ended

2022-503110-23-00 Metabolic liver disease in HIV-infected people 6 2023-05-05
A study to find and confirm the dose and assess the safety, reactogenicity and immune response of a vaccine against influenza in healthy you… Ended

2022-502308-66-00 Healthy volunteers (prevention of influenza infection) 7 2023-04-27
A Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of MK-3508 in Healthy Participants Ended

2022-502926-42-00 Respiratory syncytial virus infection 1 2023-03-30
A Study to Evaluate Investigational Therapies in Chronic Hepatitis B Virus Infection Ended

2024-513176-17-00 Chronic Hepatitis B Virus (HBV) Infection 4 2023-03-30
A study to evaluate the efficacy and safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19 Ended

2023-504540-33-00 COVID-19 5 2023-03-06